文献速递免疫规划慢病防控与筛查妇幼与学校卫生

接受生物制剂治疗的儿童中可用疫苗的效力、免疫原性与安全性:系统综述与Meta分析

Efficacy, immunogenicity, and safety of available vaccines in children on biologics: A systematic review and meta-analysis.
PubMed 文献 · Vaccine · 2022-03-31

该系统综述与Meta分析检索2009至2019年文献,最终纳入14篇进行Meta分析,评估接受生物制剂治疗的慢性病儿童接种疫苗的效力、免疫原性与安全性。接受抗肿瘤坏死因子α治疗的患儿对乙型流感疫苗血清型B的血清转化和血清保护风险显著较差,但H1N1和H3N2血清型应答充分;接种疫苗与严重副作用无关,但幼年特发性关节炎患者接种流感疫苗后出现肌痛或关节痛的风险显著。作者认为需更多证据指导该儿科人群的疫苗决策。

要点

  • 接受抗肿瘤坏死因子α治疗的患儿对乙型流感疫苗血清型B的血清转化和血清保护显著较差。
  • H1N1和H3N2血清型应答充分,但肺炎球菌、甲肝、乙肝、水痘-带状疱疹、麻腮风及多疫苗同时接种的研究较少。
  • 接种疫苗与严重副作用无关,但幼年特发性关节炎患者接种流感疫苗后肌痛或关节痛风险显著。

核心结论

  • 需要更多关于疫苗效力、免疫原性和安全性的证据来指导医生对此儿科人群的疫苗决策。

研究设计与样本

  • 系统综述与Meta分析,方案在PROSPERO注册并发表,检索2009至2019年发表的电子文献数据库,聚焦接受生物制剂治疗的慢性病儿童的疫苗接种研究。
  • 共检索到532条记录,选取31篇全文文章,最终14篇纳入Meta分析。
  • 未发现显著发表偏倚。

主要发现

  • 关于疫苗接种效力的数据有限,因为大多数研究聚焦于免疫原性作为效力的替代结局。
  • 接受抗肿瘤坏死因子α治疗的患者发生不良血清转化的风险有统计学显著意义(p=0.028),对乙型流感疫苗血清型B的血清保护风险亦有统计学显著意义(炎症性肠病 p=0.013;幼年特发性关节炎 p=0.004)。
  • 对H1N1和H3N2血清型发现足够的应答。
  • 肺炎球菌、甲型肝炎病毒、乙型肝炎病毒、水痘-带状疱疹病毒、麻疹腮腺炎风疹病毒及多疫苗同时接种的研究较少。
  • 疫苗接种与严重副作用无关,但接受抗肿瘤坏死因子α治疗的幼年特发性关节炎患者接种流感疫苗后出现肌痛或关节痛的风险有统计学显著意义(p=0.014)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 关于疫苗接种效力的数据有限,因为大多数研究聚焦于免疫原性作为效力的替代结局。
  • 肺炎球菌、甲型肝炎病毒、乙型肝炎病毒、水痘-带状疱疹病毒、麻疹腮腺炎风疹病毒及多疫苗同时接种的研究较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Vaccinations are essential for preventing infectious diseases in children with chronic diseases as they have increased risk of infection from frequent use of biologics. Response to immunizations in this group is not well known. OBJECTIVE: A systematic review was performed to evaluate three primary outcomes: efficacy; immunogenicity; and safety of vaccines in children with chronic conditions treated with biologics. METHODS: The protocol for our systematic review and meta-analysis was registered and published with PROSPERO. We searched electronic bibliographic databases for studies published from 2009 to 2019, focusing on vaccinations in children with chronic conditions treated with biologics. RESULTS: We retrieved 532 records. Thirty-one full-text articles were selected, and 14 were included in the meta-analysis. No significant publication bias was found. EFFICACY: limited data are available regarding the efficacy of vaccination, as most studies have focused on immunogenicity as surrogate outcome for efficacy. Immunogenicity: patients receiving anti-TNF-alpha therapy had a statistically significant risk of poor seroconversion (p = 0.028) and seroprotection by the serotype B influenza vaccine [inflammatory bowel disease (IBD) p = 0.013; juvenile idiopathic arthritis (JIA) p = 0.004]. We found adequate responses with H1N1 and H3N2 serotypes. Few studies existed for pneumococcal, hepatitis A virus, hepatitis B virus, varicella-zoster virus, Measles Mumps Rubella virus, and multiple vaccine administration. SAFETY: vaccine administration was not associated with serious side effects, but JIA patients on anti-TNF alpha therapy had a statistically significant risk of presenting with myalgia or arthralgia postinfluenza vaccine (p = 0.014). CONCLUSIONS: More evidence concerning efficacy, immunogenicity, and safety of vaccinations is needed to guide physicians in the vaccine decision process for this pediatric population.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gertosio C, Licari A, De Silvestri A, et al. Efficacy, immunogenicity, and safety of available vaccines in children on biologics: A systematic review and meta-analysis. Vaccine. 2022. PMID: 35370019. doi:10.1016/j.vaccine.2022.03.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。